InvestorsHub Logo
Followers 0
Posts 83
Boards Moderated 0
Alias Born 11/25/2016

Re: J_Cali post# 24301

Friday, 02/24/2017 11:41:00 AM

Friday, February 24, 2017 11:41:00 AM

Post# of 38634
I download the orange book and with some filtering i come up with 19 companies so rather than dividing by 28 i should have used 19.

APOTEX INC
NOSTRUM PHARMACEUTICALS LLC
BARR LABORATORIES INC
TEVA PHARMACEUTICALS USA INC
ACTAVIS LABORATORIES FL INC
ZYDUS PHARMACEUTICALS USA INC
MYLAN PHARMACEUTICALS INC
SUN PHARMACEUTICAL INDUSTRIES LTD
CSPC OUYI PHARMACEUTICAL CO LTD
AMNEAL PHARMACEUTICALS NY LLC
AUROBINDO PHARMA LTD
MARKSANS PHARMA LTD
MACLEODS PHARMACEUTICALS LTD
BEXIMCO PHARMACEUTICALS USA INC
BRISTOL MYERS SQUIBB CO
ACTAVIS ELIZABETH LLC
IMPAX LABORATORIES INC
RANBAXY LABORATORIES LTD
TORRENT PHARMACEUTICALS LTD

updated numbers (600/19)x12.5%=3.9M so about 1M a QTR if off by 50% (they don't manufacture the drug) then $500k per QTR again the partner will make all the difference